全文获取类型
收费全文 | 4941篇 |
免费 | 267篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 80篇 |
儿科学 | 247篇 |
妇产科学 | 55篇 |
基础医学 | 440篇 |
口腔科学 | 97篇 |
临床医学 | 447篇 |
内科学 | 973篇 |
皮肤病学 | 71篇 |
神经病学 | 228篇 |
特种医学 | 146篇 |
外科学 | 1035篇 |
综合类 | 68篇 |
一般理论 | 1篇 |
预防医学 | 238篇 |
眼科学 | 212篇 |
药学 | 412篇 |
中国医学 | 15篇 |
肿瘤学 | 477篇 |
出版年
2023年 | 43篇 |
2022年 | 106篇 |
2021年 | 220篇 |
2020年 | 99篇 |
2019年 | 150篇 |
2018年 | 213篇 |
2017年 | 133篇 |
2016年 | 170篇 |
2015年 | 179篇 |
2014年 | 232篇 |
2013年 | 270篇 |
2012年 | 430篇 |
2011年 | 393篇 |
2010年 | 239篇 |
2009年 | 201篇 |
2008年 | 306篇 |
2007年 | 322篇 |
2006年 | 251篇 |
2005年 | 199篇 |
2004年 | 197篇 |
2003年 | 176篇 |
2002年 | 128篇 |
2001年 | 51篇 |
2000年 | 62篇 |
1999年 | 57篇 |
1998年 | 24篇 |
1997年 | 22篇 |
1996年 | 30篇 |
1995年 | 15篇 |
1994年 | 15篇 |
1993年 | 13篇 |
1992年 | 37篇 |
1991年 | 22篇 |
1990年 | 19篇 |
1989年 | 14篇 |
1988年 | 16篇 |
1987年 | 13篇 |
1986年 | 12篇 |
1985年 | 16篇 |
1984年 | 14篇 |
1983年 | 12篇 |
1982年 | 9篇 |
1981年 | 7篇 |
1980年 | 11篇 |
1979年 | 7篇 |
1975年 | 8篇 |
1974年 | 7篇 |
1972年 | 12篇 |
1971年 | 6篇 |
1966年 | 5篇 |
排序方式: 共有5242条查询结果,搜索用时 15 毫秒
51.
52.
Fenretinide enhances rituximab-induced cytotoxicity against B-cell lymphoma xenografts through a caspase-dependent mechanism 下载免费PDF全文
The anti-CD20 monoclonal antibody rituximab induces remission in 40% to 60% of patients with indolent B-cell lymphoma, but virtually all patients have relapses. We evaluated the efficacy of concurrent administration of another biologic agent, N-(4-hydroxyphenyl) retinamide (4HPR, fenretinide) with rituximab against a variety of human B-cell lymphoma cell lines (Ramos, DHL-4, and FL-18) in vivo. Concurrent 4HPR and rituximab administration prevented tumor progression of lymphoma-bearing mice in a minimal disease model (rituximab + 4HPR, 100% progression free; rituximab alone, 37.5% progression free, P =.01; 4HPR alone, 12.5% progression free, P <.01; controls, 0% progression free, P <.01). Combinations of 4HPR + rituximab exceeded the predicted 50% additive rate of disease control from each agent alone (P =.038). Administering 4HPR and rituximab to mice with established tumors induced complete responses (CRs) in 80% of animals compared with 20% to 40% CRs using either agent alone (P =.07), resulting in significantly improved survival. Tumors harvested from 4HPR + rituximab-treated mice displayed elevated caspase activation compared with untreated controls (P =.02). Adding a broad-spectrum caspase inhibitor in vivo fully abrogated the antitumor effects of 4HPR + rituximab (P =.05). These results establish the efficacy of 4HPR/rituximab combinations, confirm their caspase-mediated mechanism of action, and offer the potential for disease control with minimal toxicity for patients with B-cell malignancies. 相似文献
53.
54.
Chen CH Jiang T Yang JH Jiang W Lu J Marathe GK Pownall HJ Ballantyne CM McIntyre TM Henry PD Yang CY 《Circulation》2003,107(16):2102-2108
55.
56.
57.
David A. Talan Sukhjit S. Takhar Anusha Krishnadasan William R. Mower Daniel J. Pallin Manish Garg Jon Femling Richard E. Rothman Johanna C. Moore Alan E. Jones Frank Lovecchio Jonathan Jui Mark T. Steele Amy M. Stubbs William K. Chiang Gregory J. Moran 《Annals of emergency medicine》2021,77(1):32-43
58.
CE Faggons C Mabedi CG Shores S Gopal 《Malawi medical journal : the journal of Medical Association of Malawi》2015,27(3):79-87
Aim
Review the literature from 1990 to 2013 to determine known anatomic sites, risk factors, treatments, and outcomes of head and neck squamous cell carcinoma (HNSCC) in sub-Saharan Africa.Methods
Using a systematic search strategy, literature pertaining to HNSCC in sub-Saharan Africa was reviewed and patient demographics, anatomic sites, histology, stage, treatment, and outcomes were abstracted. The contributions of human immunodeficiency virus (HIV), human papillomavirus (HPV) and behavioural risk factors to HNSCC in the region were assessed.Results
Of the 342 papers identified, 46 were utilized for review, including 8611 patients. In sub-Saharan Africa, the oropharyngeal/oral cavity was found to be the most common site, with 7750 cases (90% of all cases). Few papers distinguished oropharyngeal from oral cavity, making identification of possible HPV-associated oropharyngeal squamous cell carcinoma (SCC) difficult. SCC of the nasopharynx, nasal cavity, or paranasal sinuses was identified in 410 patients (4.8% of all cases). Laryngeal SCC was found in 385 patients (4.5% of all cases), and only 66 patients (0.8% of all cases) with hypopharyngeal SCC were identified. In 862 patients with data available, 43% used tobacco and 42% used alcohol, and reported use varied widely and was more common in laryngeal SCC than that of the oropharyngeal/oral cavity. Toombak and kola nut use was reported to be higher in patients with HNSCC. Several papers reported HIV-positive patients with HNSCC, but it was not possible to determine HNSCC prevalence in HIV-positive compared to negative patients. Reports of treatment and outcomes were rare.Conclusions
The oropharyngeal/oral cavity was by far the most commonly reported site of HNSCC reported in sub-Saharan Africa. The roles of risk factors in HNSCC incidence in sub-Saharan Africa were difficult to delineate from the available studies, but a majority of patients did not use tobacco and alcohol. 相似文献59.
Ashok Kumar Reddy Raja Rami Reddy Muralidhar Rao Paruvelli Srinivas Ambatipudi Alka Rani Sikander A. K. Lodhi Juturi Maruthi Lokabhi Reddy K. Ramakanth Reddy Niraj Pandey Rituraj Videkar Manish Kumar Sinha Ajit Babu Majji Nilanjana Deb-Jorder Atul Kumar Sahu Jyostna Myneni Anina Abraham 《International ophthalmology》2015,35(1):37-42